A phase II study of S-1 plus cisplatin with concurrent radiation for locally advanced thymic carcinoma (LOGIK1605/JART-1501)
- Conditions
- Thymic carcinoma
- Registration Number
- JPRN-UMIN000024643
- Lead Sponsor
- Clinical Research Support Center Kyushu
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 30
Not provided
1. Patients who requires urgent radiation therapy with a symptom of superior vena cava syndrome. 2. Patients with serious complications : such as uncontrollable angina pectoris, myocardial infarction within 3 months and heart failure, uncontrollable diabetes mellitus,hypertension and serious infection. 3. Patients with interstitial pneumonia confirmed by chest X-ray. 4. Patients having complications judged to affect the enforcement of treatment. 5. Patients with anamnesis of severe hypersensitivity. 6. Patients with pregnant or possibly pregnant.Patients with nursing. 7. Patients who are different for the participation in the study by complication of mental disease or psychiatric symptom. 8. Any other patients who are regarded as unsuitable for this study by the investigators.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method